ADUS:NGS-Addus HomeCare Corporation (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 103.34

Change

-0.40 (-0.39)%

Market Cap

USD 0.39B

Volume

0.08M

Analyst Target

USD 119.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

N/A

USD 6.80B
ENSG The Ensign Group Inc

N/A

USD 6.67B
OPCH Option Care Health Inc

N/A

USD 5.40B
SGRY Surgery Partners Inc

N/A

USD 3.11B
AMED Amedisys Inc

N/A

USD 3.00B
LFST Lifestance Health Group Inc

N/A

USD 2.17B
AMEH Astrana Health Inc.

N/A

USD 1.86B
ASTH Astrana Health Inc

N/A

USD 1.67B
HCSG Healthcare Services Group Inc

N/A

USD 0.80B
CCRN Cross Country Healthcare Inc

N/A

USD 0.59B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

N/A

USD 0.94M
JHMA 4.37 % 0.47 %

N/A

N/A
RTM Invesco S&P 500® Equal W.. 3.69 % 0.40 %

N/A

USD 0.28B
5HEE:F Ossiam Irl Icav - Ossiam .. 3.50 % 0.00 %

N/A

N/A
5HEE:XETRA Ossiam ESG Low Carbon Shi.. 3.50 % 0.00 %

N/A

USD 0.47B
5HED:XETRA Ossiam ESG Low Carbon Shi.. 3.50 % 0.00 %

N/A

USD 0.44B
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

N/A

USD 0.36B
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

N/A

USD 0.39B
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

N/A

USD 32.00B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

N/A

USD 7.46B
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

N/A

USD 0.09B
WMCR 0.00 % 0.50 %

N/A

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

N/A

USD 6.34B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.30% 76% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.30% 76% C+ 74% C
Trailing 12 Months  
Capital Gain 0.49% 57% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.49% 57% F 46% F
Trailing 5 Years  
Capital Gain 62.51% 45% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.51% 45% F 74% C
Average Annual (5 Year Horizon)  
Capital Gain 5.11% 64% D 63% D
Dividend Return 5.11% 64% D 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.69% 100% F 75% C
Risk Adjusted Return 24.72% 68% D+ 62% D
Market Capitalization 0.39B 71% C- 78% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 49.30 70% 35%
Price/Book Ratio 2.37 54% 42%
Price / Cash Flow Ratio 14.94 38% 19%
Price/Free Cash Flow Ratio 16.75 33% 15%
Management Effectiveness  
Return on Equity 9.33% 82% 74%
Return on Invested Capital 9.78% 74% 79%
Return on Assets 6.18% 90% 89%
Debt to Equity Ratio 17.57% 62% 61%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.